Insecticidal activity of Simparica and Simparica Trio against Aedes aegypti in dogs. [PDF]
Geurden T +6 more
europepmc +1 more source
Sarolaner, a novel parasiticide in the treatment of generalized demodicosis in dogs-a case study
Bhargavi Matli +2 more
openaire +1 more source
Neurological adverse effects of isoxazoline exposure in cats and dogs
Background: Isoxazolines are rarely reported to be associated with neurological adverse events in cats and dogs, but information about the onset and duration of neurological signs is lacking in the summary of product characteristics of these medicines ...
Edwards, John Nicholas +3 more
core
Therapeutic management of generalized canine Demodicosis with Simparica® (Sarolaner): A case report
S Sinha +6 more
openaire +1 more source
Clinical, Histopathological and Epidemiological Features of Dorsal Melanotrichia of Poodles and Poodle Crosses. [PDF]
Kim J +6 more
europepmc +1 more source
International audienceA retrospective study was conducted du the French National Agency for Veterinary Medicines to analyse and compare adverse reactions reported in France in cats between 2019 and 2023for three pairs of spot-on antiparasiticide ...
Demay, Flore +5 more
core
Comparison of the initial and residual speed of Amblyomma americanum kill on dogs treated with a single dose of Bravecto® Chew (25 mg/kg fluralaner) or Simparica TRIO® (1.2 mg/kg sarolaner, 24 µg/kg moxidectin, 5 mg/kg pyrantel). [PDF]
Reif KE +8 more
europepmc +1 more source
Evaluation of efficacy and pharmacokinetics of novel fluralaner tablet formulation (WellPet™) in dogs. [PDF]
Cruz BC +8 more
europepmc +1 more source
Efficacy of Credelio Quattro™ chewable tablets containing lotilaner, moxidectin, pyrantel, and praziquantel against Ctenocephalides felis and Rhipicephalus sanguineus infestations on dogs. [PDF]
Young L +7 more
europepmc +1 more source

